View in EDS PDF Full Text

Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL.

Saved in:
Bibliographic Details
Title: Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL.
Authors: Mascolo A; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy., Di Napoli R; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy., Balzano N; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy., D'Alessio E; Pharmacy Unit, Ospedale del Mare-A.S.L. Na1-Centro, Naples, Italy., Izzo I; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy., Rossi F; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy., Paolisso G; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy., Capuano A; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy., Sportiello L; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy.
Source: Frontiers in pharmacology [Front Pharmacol] 2023 Aug 16; Vol. 14, pp. 1229304. Date of Electronic Publication: 2023 Aug 16 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37654615
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mascolo+A%22">Mascolo A</searchLink>; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Di+Napoli+R%22">Di Napoli R</searchLink>; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Balzano+N%22">Balzano N</searchLink>; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22D'Alessio+E%22">D'Alessio E</searchLink>; Pharmacy Unit, Ospedale del Mare-A.S.L. Na1-Centro, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Izzo+I%22">Izzo I</searchLink>; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Rossi+F%22">Rossi F</searchLink>; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Paolisso+G%22">Paolisso G</searchLink>; Department of Advanced Medical and Surgical Sciences, University of Campania 'Luigi Vanvitelli', Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Capuano+A%22">Capuano A</searchLink>; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Sportiello+L%22">Sportiello L</searchLink>; Campania Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Napoli, Italy.; Department of Experimental Medicine-Section of Pharmacology 'L. Donatelli', University of Campania 'Luigi Vanvitelli', Napoli, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2023 Aug 16; Vol. 14, pp. 1229304. <i>Date of Electronic Publication: </i>2023 Aug 16 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37654615
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2023.1229304
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1229304
    Titles:
      – TitleFull: Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mascolo A
      – PersonEntity:
          Name:
            NameFull: Di Napoli R
      – PersonEntity:
          Name:
            NameFull: Balzano N
      – PersonEntity:
          Name:
            NameFull: D'Alessio E
      – PersonEntity:
          Name:
            NameFull: Izzo I
      – PersonEntity:
          Name:
            NameFull: Rossi F
      – PersonEntity:
          Name:
            NameFull: Paolisso G
      – PersonEntity:
          Name:
            NameFull: Capuano A
      – PersonEntity:
          Name:
            NameFull: Sportiello L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 08
              Text: 2023 Aug 16
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1